The risk of traffic accidents after prescriptions of carisoprodol

被引:31
作者
Bramness, Jorgen G.
Skurtveit, Svetlana
Morland, Jorg
Engeland, Anders
机构
[1] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Div Epidemiol, NO-0403 Oslo, Norway
[2] Univ Tromso, Dept Pharm, N-9001 Tromso, Norway
[3] Norwegian Inst Publ Hlth, Div Forens Toxicol & Drug Abuse, Oslo, Norway
[4] Univ Oslo, Inst Pharmacol, Oslo, Norway
[5] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, Bergen, Norway
关键词
pharmacoepidemiology; traffic injury; carisoprodol; meprobamate; diazepam; salbutamol;
D O I
10.1016/j.aap.2007.02.002
中图分类号
TB18 [人体工程学];
学科分类号
1201 [管理科学与工程];
摘要
Objective: Carisoprodol, a drug used for acute lower back pain, may cause psychomotor impairment. We wanted to investigate if patients using carisoprodol had increased risk of being involved in a traffic accident. Methods: Data were retrieved from three population-based registries for the period April 2004-September 2005. The Norwegian Prescription Database contained individual information on all dispensed drugs at all pharmacies outside hospitals. The Norwegian Road Accident Registry contained information on all drivers involved in motor vehicle accidents with person injury. The Norwegian Central Population Registry was used to control for emigration or death. The accident incidence among carisoprodol exposed and unexposed subjects was compared by standardized incidence ratio. Results: Having a prescription for carisoprodol dispensed increased the standardized incidence ratio for being involved in an accident with person injury to 3.7 (95% CI 2.9-4.8) the first week after the date of dispensing. This was similar to diazepam (2.8; 2.2-3.6), but higher than for salbutamol (1.1; 0.6-1.8). Conclusions: Patients receiving carisoprodol seem to have an increased risk of being involved in traffic accidents involving person injury. The study gives support to earlier work published on the impairing effects of carisoprodol. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1050 / 1055
页数:6
相关论文
共 45 条
[1]
[Anonymous], 2005, GUID ATC CLASS DDD A
[2]
[Anonymous], NOR J EPIDEMIOL
[3]
[Anonymous], 2003, HOSP PHARM
[4]
Codeine and clinical impairment in samples in which morphine is not detected [J].
Bachs, L ;
Skurtveit, S ;
Morland, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (12) :785-789
[5]
Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment [J].
Bachs, Liliana ;
Hoiseth, Gudrun ;
Skurtveit, Svetlana ;
Morland, Jorg .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (11) :905-912
[6]
Association of road-traffic accidents with benzodiazepine use [J].
Barbone, F ;
McMahon, AD ;
Davey, PG ;
Morris, AD ;
Reid, IC ;
McDevitt, DG ;
MacDonald, TM .
LANCET, 1998, 352 (9137) :1331-1336
[7]
Borkenstein RF, 1974, BLUTALKOHOL S1, V11, P1
[8]
Bramness J G, 2000, Tidsskr Nor Laegeforen, V120, P1966
[9]
Carisoprodol intoxications and serotonergic features [J].
Bramness, JG ;
Morland, J ;
Sorlid, HK ;
Rudberg, N ;
Jacobsen, D .
CLINICAL TOXICOLOGY, 2005, 43 (01) :39-45
[10]
Impairment due to intake of carisoprodol [J].
Bramness, JG ;
Skurtveit, S ;
Morland, J .
DRUG AND ALCOHOL DEPENDENCE, 2004, 74 (03) :311-318